Literature DB >> 7397040

Combined use of phenoxybenzamine and dopamine for low cardiac output syndrome in children at withdrawal from cardiopulmonary bypass.

M Kawamura, O Minamikawa, H Yokochi, S Maki, T Yasuda, Y Mizukawa.   

Abstract

The combined use of phenoxybenzamine and dopamine was applied in infants and children when it was difficult to come off cardiopulmonary bypass for low cardiac output. The rationale of this method is to prevent the alpha-adrenergic action of dopamine by phenoxybenzamine and to encourage the beta-adrenergic and direct specific action of dopamine. Dopamine was used in dosage of 10 to 30 micrograms/kg per min after the additional administration of a half of the initial dosage of phenoxybenzamine; this was infused by drip always in a dosage of 0.5 to 1.0 mg/kg during the first half of cardiopulmonary bypass. It was possible to come off cardiopulmonary bypass with a stable haemodynamic state (mean arterial pressure more than 60 mmHg and total peripheral vascular resistance less than 2000 bynes s cm-5) and a good urinary output.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7397040      PMCID: PMC482297          DOI: 10.1136/hrt.43.4.388

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

Review 1.  Dopamine--clinical uses of an endogenous catecholamine.

Authors:  L I Goldberg
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

Review 2.  Cardiovascular and renal actions of dopamine: potential clinical applications.

Authors:  L I Goldberg
Journal:  Pharmacol Rev       Date:  1972-03       Impact factor: 25.468

3.  Effects of dopamine on myocardial metabolism in patients with ischaemic heart disease.

Authors:  C Crexells; M G Bourassa; P Biron
Journal:  Cardiovasc Res       Date:  1973-07       Impact factor: 10.787

4.  The potential role of dopamine in the treatment of shock.

Authors:  L I Goldberg; R C Talley; J L McNay
Journal:  Prog Cardiovasc Dis       Date:  1969-07       Impact factor: 8.194

5.  Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor.

Authors:  B K Yeh; J L McNay; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1969-08       Impact factor: 4.030

6.  Cardiovascular effects of dopamine in the anesthetized cat.

Authors:  G Ross; A W Brown
Journal:  Am J Physiol       Date:  1967-04

7.  Cardiovascular function in shock. Responses to volume loading and isoproterenol infusion.

Authors:  J S Carey; R S Brown; P A Mohr; D O Monson; S T Yao; W C Shoemaker
Journal:  Circulation       Date:  1967-02       Impact factor: 29.690

8.  Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow.

Authors:  J L McNay; L I Goldberg
Journal:  J Pharmacol Exp Ther       Date:  1966-01       Impact factor: 4.030

9.  The treatment of cardiogenic shock. 3. The use of isoproterenol in cardiogenic shock.

Authors:  L W Eichna
Journal:  Am Heart J       Date:  1967-12       Impact factor: 4.749

10.  Action of drugs in patients early after cardiac surgery. I. Comparison of isoproterenol and dopamine.

Authors:  E L Holloway; E B Stinson; G C Derby; D C Harrison
Journal:  Am J Cardiol       Date:  1975-05       Impact factor: 2.778

View more
  1 in total

1.  Effects of dopamine and dobutamine on the myocardial and systemic circulation during and following cardiopulmonary bypass in dogs.

Authors:  H B Ward; S Einzig; R W Bianco; T Wang; J E Foker
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.